Evidence map›Paper›PMID 38836873›Full record

ArticleArchives of women's mental health2024

Sex differences in patient-reported outcome measure of psychotic symptoms in schizophrenia.

Regina Vila-Badia, Susana Ochoa, Julia Fábrega-Ruz, Juan Luis Gonzalez-Caballero, Cristina Romero, Jordi Cid, Eva Frigola-Capell, Luis Salvador-Carulla, Berta Moreno-Küstner

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of women's mental health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Regina Vila-BadiaInstitut de Recerca Sant Joan de Déu, Parc Sanitari Sant Joan de Déu, Esplugues de Llobregat, Sant Boi de Llobregat. CIBERSAM, Spain. regina.vilab@sjd.es.ORCID 0000-0001-8819-3991
Susana OchoaInstitut de Recerca Sant Joan de Déu, Parc Sanitari Sant Joan de Déu, Esplugues de Llobregat, Sant Boi de Llobregat. CIBERSAM, Spain.
Julia Fábrega-RuzMental Health Department, Hospital Regional Universitario de Málaga, University of Malaga, Malaga, Spain.
Juan Luis Gonzalez-CaballeroDepartment of Statistics and Operational Research, Faculty of Medicine, University of Cádiz, Cadiz, Spain.
Cristina RomeroDepartment of Psychology, University of Cádiz, Asociación Científica Psicost, Cadiz, Spain.
Jordi CidMental Health & Addiction Research Group, Institut d'Assistència Sanitària (IAS), Institut d'Investigació Biomèdica de Girona (IDIBGI), Girona, Spain.
Eva Frigola-CapellMental Health & Addiction Research Group, Institut d'Assistència Sanitària (IAS), Institut d'Investigació Biomèdica de Girona (IDIBGI), Girona, Spain.
Luis Salvador-CarullaDeputy Director, Health Research Institute, University of Canberra, Canberra, Australia.
Berta Moreno-KüstnerDepartment of Personality, Assessment and Psychological Treatment, Andalusian Group of Psychosocial Research (GAP), University of Malaga, Biomedical Research Institute of Malaga (IBIMA), Malaga, Spain.

Funding

Instituto de Salud Carlos III PI16/00647
6 · The paper itself

Abstract

purposeto study sex differences in self-reported symptoms measured with the Scale of Patient-Reported Impact of Symptoms in Schizophrenia (PRISS), to investigated sex differences in the degree of agreements between self-reported symptoms and clinical symptoms assessed by professionals, and to identify which clinical and sociodemographic variables predicted a greater presence of self-reported symptoms split by sex.

methods161 patients (37 females; 124 males), aged between 18 and 65 years, with a diagnosis of schizophrenia assisted in non-acute mental health services at four mental health catchment areas in Andalucia and Catalonia were included. The PRISS scale was administered to asses self-reported symptoms.

resultsmales reported higher presence of excitement, grandiosity, motor retardation and poor attention) than women. There was less agreement in the presence of psychotic symptoms in men than in women when comparing self-reported symptoms and clinical symptoms assessed by professionals. Finally, in men the predictors variables for the greater presence of self-perceived symptoms were greater psychotic symptomatology and more disability, while in women were greater presence of alogia and higher doses of chlorpromazine.

conclusionsAssessing and being aware of the self-perceived symptoms of patients with schizophrenia should be considered in the clinic, especially in men, as there appears to be a lack of agreement on certain items. This would allow treatments to be more focused on patients' need by sex, and would make them feel part of the therapeutic process, improving their therapeutic adherence, evolution and quality of life.

Indexed as

Patient Reported Outcome MeasuresSchizophreniaSchizophrenic PsychologySelf ReportAdolescentAdultAgedAntipsychotic AgentsFemaleHumansMaleMiddle AgedPsychiatric Status Rating ScalesPsychotic DisordersSex FactorsSpainAntipsychotic AgentsPRISS scalePsychotic symptomsSchizophreniaSelf-perceived symptomsSex

Identifiers

PMID38836873

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.